Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
The heterogeneity of tumor evolution from AR-positive, adenocarcinoma to AR-negative, neuroendocrine prostate cancer (NEPC) is not fully characterized. Here the authors generate a mouse model to show that Rb1 loss and MYCN overexpression accelerates the progression to AR-negative NEPC and identify e...
Guardado en:
Autores principales: | Nicholas J. Brady, Alyssa M. Bagadion, Richa Singh, Vincenza Conteduca, Lucie Van Emmenis, Elisa Arceci, Hubert Pakula, Ryan Carelli, Francesca Khani, Martin Bakht, Michael Sigouros, Rohan Bareja, Andrea Sboner, Olivier Elemento, Scott Tagawa, David M. Nanus, Massimo Loda, Himisha Beltran, Brian Robinson, David S. Rickman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02a3612e2f2a462990758033d59bb602 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
por: Ada Gjyrezi, et al.
Publicado: (2021) -
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
por: Kyrillus S. Shohdy, et al.
Publicado: (2021) -
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer
por: Meixia Che, et al.
Publicado: (2021) -
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
por: Brian D. Robinson, et al.
Publicado: (2019) -
Patient derived organoids to model rare prostate cancer phenotypes
por: Loredana Puca, et al.
Publicado: (2018)